Omega Funds — 2014 Investments

2 investments dated 2014 · listed companies and verified rows first · show all

Lysosomal Therapeuticslysosomaltx.orgSeed · May 2014 · $5M

Lysosomal Therapeutics Inc.

BiotechCambridge, US

Dimitri Krainc(Director)Robert Carpenter(Executive Officer, Director)Cornelis Been(Executive Officer, Director)

BoardSteven Hall(Director)Carole Nuechterlein(Director)inBernard Davitian(Director)

Co-investorsSanofi Ventures Atlas Venture Hatteras Venture Partners Lilly Ventures Roche Venture Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Andrew Alliance

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.